Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

Does prostate-cancer screening with the common ‘PSA’ blood test save lives? The Cochrane, an influential group renowned for its gold-standard medical reviews, has previously addressed that question ...

Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising concerns about overtesting" warn researchers from the University of Oxford ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis. Prostate-specific antigen (PSA) ...

Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted Breakthrough Device Designation by the FDA for its ArteraAI Prostate, an AI-enabled tool ...

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...

Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found. Researchers from the University of Oxford examined the health records ...

The Decipher Prostate test is already widely used in the US to help identify localised prostate cancer more likely to spread. It becomes the first molecular test with clinical evidence from a ...